SCHEMBL3175121

SCHEMBL3175121

CC(=O)Cc1cc(O)cc(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AB1 P08238 1/20 0.59
▸ CA5A P35218 1/20 0.48
▸ ACHE P22303 1/20 0.46
▸ LMNA P02545 1/20 0.43
▸ CYP3A4 P08684 4/20 0.41
▸ PTGS2 P35354 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HPGD P15428 1/20 0.41
▸ BACE1 P56817 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ CA12 O43570 3/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39
▸ CA7 P43166 3/20 0.39
▸ CA9 Q16790 3/20 0.39
▸ CA14 Q9ULX7 3/20 0.39
▸ PTGS1 P23219 1/20 0.37
▸ DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28721957 0.79 HSP90AB1 (0.58) HSP90AB1CA5AACHELMNACYP3A4
SCHEMBL3192007 0.78 SELP (0.42) HSP90AB1CA5ALMNAHPGDPOLB
SCHEMBL200141 0.78 CTBP2 (0.56) CA5ALMNACYP3A4KMT2ACA12
SCHEMBL477986 0.77 CA2 (0.58) HSP90AB1ACHELMNAMEN1KMT2A
SCHEMBL8936329 0.76 HSP90AB1 (0.55) HSP90AB1CA5AACHELMNACYP3A4
SCHEMBL27896449 0.76 POLB (0.42) HSP90AB1CA5AHPGDPOLB
Phloroglucinol SCHEMBL28617918 0.76 ALDH1A1 (0.59) HSP90AB1CA5AACHELMNACYP3A4
SCHEMBL12081769 0.75 RXRA (0.44) HSP90AB1CYP3A4PTGS2MEN1KMT2A
SCHEMBL10865907 0.75 TPMT (0.42) CYP3A4MEN1KMT2APOLB
SCHEMBL13438518 0.75 AKR1B1 (0.48) LMNAMEN1KMT2AHPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2020-07-02 — — US claimed
US-20130298933-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2013-11-14 — — US claimed
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL S.A. (FR) 2010-12-02 — — US claimed
EP-4554549-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2025-05-21 — — EP disclosed
CN-119677492-A Composition comprising a skin care active or a cellulose compound 莱雅公司 2025-03-21 — — CN disclosed
US-20250064703-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL OREAL (FR) 2025-02-27 — — US disclosed
EP-4452205-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL L'OREAL (FR) 2024-10-30 — — EP disclosed
CN-118542820-A Topical delivery system for active ingredients 莱雅公司 2024-08-27 — — CN disclosed
CN-118414140-A Compositions comprising dissolved polyphenols 莱雅公司 2024-07-30 — — CN disclosed
EP-4337159-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT AND TWO POLYGLYCERYL FATTY ACID ESTERS L'OREAL (FR) 2024-03-20 — — EP disclosed
WO-2024014310-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2024-01-18 — — WO disclosed
EP-3171853-A1 COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE L'Oréal (FR) 2017-05-31 — — EP disclosed
US-20170087064-A1 COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE L'OREAL (FR) 2017-03-30 — — US disclosed
WO-2015198922-A1 COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE L'OREAL (FR) 2015-12-30 — — WO disclosed
US-20140326268-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS L'OREAL (FR) 2014-11-06 — — US disclosed
US-8765107-B2 Process for straightening keratin fibres with a heating means and denaturing agents L'OREAL (FR) 2014-07-01 — — US disclosed
US-20130298933-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2013-11-14 — — US disclosed
US-20120192888-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS L 'Oréal S.A., (FR) 2012-08-02 — — US disclosed
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL S.A. (FR) 2010-12-02 — — US disclosed
US-20100028280-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS L'OREAL S.A. (FR) 2010-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120192888-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS KRT18, KRTCAP2, TUBB4A HSP90AB1 60/4885CA5A 1915/4885ACHE 2379/4885
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B HSP90AB1 405/4885CA5A 450/4885ACHE 4025/4885
US-20100028280-A1 PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS KRT18, KRTCAP2, TUBB4A HSP90AB1 60/4885CA5A 1915/4885ACHE 2379/4885
US-20250064703-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL PROC, GANC, LGALS1 HSP90AB1 1012/4885CA5A 2011/4885ACHE 2711/4885
US-20170087064-A1 COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE LRAT, LIPA, DAGLA HSP90AB1 2699/4885CA5A 3443/4885ACHE 2486/4885
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B HSP90AB1 405/4885CA5A 450/4885ACHE 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback